Publicaciones en colaboración con investigadores/as de University of Cagliari (63)

2024

  1. A New Class of Benzo[b]thiophene-chalcones as Cholinesterase Inhibitors: Synthesis, Biological Evaluation, Molecular Docking and ADME Studies

    Molecules , Vol. 29, Núm. 16

2023

  1. 2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 38, Núm. 1

  2. Design of 3-Phenylcoumarins and 3-Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies

    ChemMedChem, Vol. 18, Núm. 21

2022

  1. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

  2. Hydroxy-3-Phenylcoumarins as Multitarget Compounds for Skin Aging Diseases: Synthesis, Molecular Docking and Tyrosinase, Elastase, Collagenase and Hyaluronidase Inhibition, and Sun Protection Factor

    Molecules, Vol. 27, Núm. 20

  3. Structural Insight of New Butyrylcholinesterase Inhibitors Based on Benzylbenzofuran Scaffold

    Pharmaceuticals, Vol. 15, Núm. 3

2020

  1. Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans

    International Journal of Biological Macromolecules, Vol. 162, pp. 774-780

  2. Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2577-2587

2019

  1. Antibacterial Activity and Molecular Docking Studies of a Selected Series of Hydroxy-3-arylcoumarins

    Molecules (Basel, Switzerland), Vol. 24, Núm. 15

  2. Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels

    Future Medicinal Chemistry, Vol. 11, Núm. 3, pp. 179-191

  3. Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives

    Bioorganic Chemistry, Vol. 84, pp. 302-308

2018

  1. Coumarin derivatives as promising xanthine oxidase inhibitors

    International Journal of Biological Macromolecules, Vol. 120, pp. 1286-1293

  2. Evaluation of trypanocidal and antioxidant activities of a selected series of 3-amidocoumarins

    Medicinal Chemistry, Vol. 14, Núm. 6, pp. 573-584

  3. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease

    Scientific Reports, Vol. 8, Núm. 1

  4. Targeting α -(1,4)-glucosidase in diabetes mellitus type 2: The role of new synthetic coumarins as potent inhibitors

    Current Topics in Medicinal Chemistry, Vol. 18, Núm. 27, pp. 2327-2337

  5. Unexpected one-step synthesis of 3-benzoyl-2-phenylbenzofurans under Wittig conditions

    Tetrahedron Letters, Vol. 59, Núm. 18, pp. 1711-1714

2017

  1. Coumarins as promising scaffold for the treatment of age-related diseases – an overview of the last five years

    Current Topics in Medicinal Chemistry, Vol. 17, Núm. 29, pp. 3173-3189

  2. MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis,: in vitro study, and docking calculations

    MedChemComm, Vol. 8, Núm. 9, pp. 1788-1796

  3. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies

    Bioorganic and Medicinal Chemistry, Vol. 25, Núm. 5, pp. 1687-1695

2016

  1. 2-Phenylbenzofuran derivatives as butyrylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling

    Bioorganic and Medicinal Chemistry Letters, Vol. 26, Núm. 9, pp. 2308-2313